Update on the management of inflammatory bowel disease: specific role of adalimumab

por Guidi, Luisa, Pugliese, Daniela, Armuzzi, Alessandro
Publicado 2011

TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine

por Felice, Carla, Pugliese, Daniela, Guidi, Luisa
Publicado 2019

Treatment of Crohn’s disease with colony-stimulating factors: An overview

por Guidi, Luisa, Mocci, Giammarco, Marzo, Manuela, Rutella, Sergio
Publicado 2008

Mucosal healing in ulcerative colitis: surveillance or colectomy?

por Andrisani, Gianluca, Papa, Alfredo, Guidi, Luisa, Armuzzi, Alessandro
Publicado 2013

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab

por Armuzzi, Alessandro, Pugliese, Daniela, Nardone, Olga Maria, Guidi, Luisa
Publicado 2013

Glucagon-like peptide-2 analogues for Crohn’s disease patients with short bowel syndrome and intestinal failure

por Pizzoferrato, Marco, Puca, Pierluigi, Ennas, Sara, Cammarota, Giovanni, Guidi, Luisa
Publicado 2022

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis

por Pugliese, Daniela, Felice, Carla, Landi, Rosario, Papa, Alfredo, Guidi, Luisa, Armuzzi, Alessandro
Publicado 2016

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases

por Privitera, Giuseppe, Pugliese, Daniela, Rapaccini, Gian Ludovico, Gasbarrini, Antonio, Armuzzi, Alessandro, Guidi, Luisa
Publicado 2021

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches

por Privitera, Giuseppe, Pugliese, Daniela, Lopetuso, Loris Riccardo, Scaldaferri, Franco, Neri, Matteo, Guidi, Luisa, Gasbarrini, Antonio, Armuzzi, Alessandro
Publicado 2021

Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy

por Pietropaolo, Giuseppe, Pugliese, Daniela, Armuzzi, Alessandro, Guidi, Luisa, Gasbarrini, Antonio, Rapaccini, Gian Lodovico, Wolf, Federica I., Trapani, Valentina
Publicado 2020

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study

por Pugliese, Daniela, Aratari, Annalisa, Festa, Stefano, Ferraro, Pietro Manuel, Monterubbianesi, Rita, Guidi, Luisa, Scribano, Maria Lia, Papi, Claudio, Armuzzi, Alessandro
Publicado 2018

Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach

por Corsello, Antonio, Pugliese, Daniela, Bracci, Fiammetta, Knafelz, Daniela, Papadatou, Bronislava, Aloi, Marina, Cucchiara, Salvatore, Guidi, Luisa, Gasbarrini, Antonio, Armuzzi, Alessandro
Publicado 2021

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver

por Lopetuso, Loris Riccardo, Mocci, Giammarco, Marzo, Manuela, D’Aversa, Francesca, Rapaccini, Gian Lodovico, Guidi, Luisa, Armuzzi, Alessandro, Gasbarrini, Antonio, Papa, Alfredo
Publicado 2018

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis

por Alivernini, Stefano, Pugliese, Daniela, Tolusso, Barbara, Bui, Laura, Petricca, Luca, Guidi, Luisa, Mirone, Luisa, Rapaccini, Gian Ludovico, Federico, Francesco, Ferraccioli, Gianfranco, Armuzzi, Alessandro, Gremese, Elisa
Publicado 2018

Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome

por Passerini, Laura, Di Nunzio, Sara, Gregori, Silvia, Gambineri, Eleonora, Cecconi, Massimiliano, Seidel, Markus G, Cazzola, Giantonio, Perroni, Lucia, Tommasini, Alberto, Vignola, Silvia, Guidi, Luisa, Roncarolo, Maria G, Bacchetta, Rosa
Publicado 2011

FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents

por Guidi, Luisa, Felice, Carla, Procoli, Annabella, Bonanno, Giuseppina, Martinelli, Enrica, Marzo, Manuela, Mocci, Giammarco, Pugliese, Daniela, Andrisani, Gianluca, Danese, Silvio, De Vitis, Italo, Papa, Alfredo, Armuzzi, Alessandro, Rutella, Sergio
Publicado 2013

Linking estrogen receptor β expression with inflammatory bowel disease activity

por Pierdominici, Marina, Maselli, Angela, Varano, Barbara, Barbati, Cristiana, Cesaro, Paola, Spada, Cristiano, Zullo, Angelo, Lorenzetti, Roberto, Rosati, Marco, Rainaldi, Gabriella, Limiti, Maria Rosaria, Guidi, Luisa, Conti, Lucia, Gessani, Sandra
Publicado 2015

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammat...

por Scaldaferri, Franco, Pugliese, Daniela, Privitera, Giuseppe, Onali, Sara, Lopetuso, Loris Riccardo, Rizzatti, Gianenrico, Settanni, Carlo Romano, Pizzoferrato, Marco, Schiavoni, Elisa, Turchini, Laura, Amatucci, Valeria, Napolitano, Daniele, Bernabei, Tiziana, Mora, Vincenzina, Laterza, Lucrezia, Papa, Alfredo, Guidi, Luisa, Rapaccini, Gian Lodovico, Gasbarrini, Antonio, Armuzzi, Alessandro
Publicado 2020

Incident Colorectal Cancer in Inflammatory Bowel Disease

por Neri, Benedetto, Scribano, Maria Lia, Armuzzi, Alessandro, Castiglione, Fabiana, D’Incà, Renata, Orlando, Ambrogio, Festa, Stefano, Riegler, Gabriele, Fries, Walter, Meucci, Gianmichele, Alvisi, Patrizia, Mocciaro, Filippo, Papi, Claudio, Mossa, Michelangela, Sena, Giorgia, Guidi, Luisa, Testa, Anna, Renna, Sara, Frankovic, Iris, Viola, Anna, Patturelli, Marta, Chiaramonte, Carlo, Biancone, Livia
Publicado 2022